Jiménez-Fonseca, Paula <br/><br/>
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer.  [electronic resource] 

 -  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association  May 2017 
 - 465-474 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1436-3305 
<br/><br/><label>Standard No.: </label>10.1007/s10120-016-0639-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptor, ErbB-2--metabolism<br/>Spain<br/>Stomach Neoplasms--drug therapy<br/>Trastuzumab--administration & dosage